A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection

Clinical trial NCT02498015 · COMPLETED

Trial details

NCT number: NCT02498015
Sponsor: Kirby Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2016-08-01
Primary completion: 2017-08-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.